查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
主動脈瘤市場規模、份額和趨勢分析報告：按類型（TAA、AAA）、按治療（OSR、EVAR）、按產品（支架移植物、導管）、按最終用戶、按地區、分部預測，2022~2030
市場調查報告書
商品編碼
1122255

主動脈瘤市場規模、份額和趨勢分析報告：按類型（TAA、AAA）、按治療（OSR、EVAR）、按產品（支架移植物、導管）、按最終用戶、按地區、分部預測，2022~2030

Aortic Aneurysm Market Size, Share & Trends Analysis Report By Type (TAA, AAA), By Treatment (OSR, EVAR), By Product (Stent Grafts, Catheters), By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 140 Pages | 商品交期: 2-10個工作天內

價格

主動脈瘤市場增長和趨勢

根據Grand View Research, Inc.最新報告，到2030年全球主動脈瘤市場規模將達到65億美元，到2030年全球主動脈瘤治療市場規模將達到104億美元，到2022年. 預計2020-2030年復合年增長率為10.51%。

發達國家老年人口的增長、久坐不動的生活方式的迅速採用以及吸煙者人數的增加預計將成為推動全球市場的主要因素。美國心臟協會（American Heart Association Inc.）發表的一項研究發現，大於 4 厘米的 AAAs 的超額患病率中有 75% 被認為是由吸煙引起的。此外，血管內手術的技術進步將促進行業增長。

腹主動脈瘤的病例數，特別是在 65 歲及以上的男性中，是胸主動脈瘤病例數的三倍。這增加了 AAA 對先進覆膜支架系統的需求。由於缺乏多種治療選擇和程序的複雜性，TAA 手術的數量很少。這為製造商開髮用於胸腔內動脈瘤修復 (TEVAR) 的先進產品提供了有利可圖的機會。

COVID-19 大流行對 AA 市場產生了負面影響。許多政府機構，包括美國外科醫師學會和法國血管外科學會，都建議推遲簡單的 AA 手術。許多醫院限制與主動脈疾病相關的手術，更喜歡 EAVR 而非開放手術。結果，用於治療主動脈疾病的設備的銷售額直線下降。例如，Microport Scientific Corporation 的血管內業務部門的收入將在 2021 年下降 42.1%。

主動脈瘤市場報告亮點

按類型劃分，AAA 細分市場在 2021 年佔據市場主導地位。AAA 病例數量的增加、政府早期篩查項目的存在以及對微創手術的需求不斷增長正在推動這一細分市場

按產品劃分，支架移植物將佔 2021 年最大的收入份額，因為它們佔患者手術總成本的 50% 以上

從最終用戶來看，由於技術進步和手術數量的增加，預計對醫院的銷售將強勁。

通過治療方式，涉及微創手術的血管內主動脈瘤修復（EVAR）預計將成為預測期內增長最快的部分，因為它比開放式修復更有效，術後副作用更少。

北美將在 2021 年佔據最大的銷售額份額，其次是歐洲。這是由於完善的醫療基礎設施、先進的 AAA 篩查和診斷工具的可用性以及該地區有利的報銷方案。

2021年8月，Terumo Corporation 獲得美國 FDA 批准上市 RelayPro 胸腔支架移植系統，用於治療胸主動脈瘤和穿透性動脈硬化性潰瘍患者。

目錄

第一章研究範圍與目的

  • 市場細分
  • 區域範圍
  • 研究目標

第二章研究方法論

  • 調查方法
    • 信息採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 型號詳情
    • 量價分析
  • 二級信息列表
  • 縮略語表

第三章執行摘要

  • 市場展望
  • 分部展望
    • 類型
    • 過程
    • 產品
    • 最終用途
  • 區域展望
  • 競爭考慮

第 4 章市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場展望
    • 相關/子公司市場展望
  • 主動脈瘤市場動態
    • 市場驅動力分析
    • 市場約束分析
  • 主動脈瘤市場：商業環境分析工具
    • 波特五力分析
      • 新進入者的威脅
      • 買方議價能力
      • 競爭對手之間的競爭
      • 替代品的威脅
      • 供應商的議價能力
    • 杵分析
      • 政治與法律
      • 經濟與社會
      • 技術的
  • 繪製滲透率和增長前景
  • 定性分析：COVID-19 對主動脈瘤市場的影響

5. 主動脈瘤市場：類型分析

  • 2021 年和 2030 年主動脈瘤類型市場份額分析
  • 主動脈瘤類型市場：細分儀表板
  • 類型細分市場規模和預測，趨勢分析，2016-2030
    • 胸主動脈瘤 (TAA)
    • 腹主動脈瘤 (AAA)

6 主動脈瘤市場：治療分析

  • 2021 年和 2030 年主動脈瘤治療市場份額分析
  • 主動脈瘤治療市場：細分儀表板
  • 2016-2030年治療細分市場規模及預測、趨勢分析
    • 開放式手術修復 (OSR)
    • 血管內動脈瘤修復（EVAR）

7. 主動脈瘤市場：產品分析

  • 2021 年和 2030 年主動脈瘤產品市場份額分析
  • 主動脈瘤產品市場：細分儀表板
  • 產品細分市場規模和預測，趨勢分析，2016-2030
    • 覆膜支架
    • 導管

8 主動脈瘤市場：最終用途分析

  • 2021 年和 2030 年主動脈瘤最終用途市場份額分析
  • 主動脈瘤最終用途市場：細分儀表板
  • 2016-2030 年最終用途細分市場規模及預測及趨勢分析
    • 醫院
    • 門診手術中心
    • 診所

9. 主動脈瘤市場：區域分析

  • 2021 年和 2030 年主動脈瘤區域市場份額分析
  • 區域市場快照
  • 2016-2030 年市場規模、預測和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 澳大利亞
      • 韓國
    • 拉丁美洲
      • 墨西哥
      • 巴西
    • 中東和非洲
      • 南非
      • 沙特阿拉伯

第 10 章 競爭分析

  • 主要市場參與者的最新發展和影響分析
  • 競爭對手分類（主要創新者、市場領導者、初創企業）
  • 公司市場分析
  • 公司簡介
    • MEDTRONIC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • TERUMO CORPORATION
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • ENDOLOGIX LLC
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • MICROPORT SCIENTIFIC CORPORATION
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • GORE MEDICAL（WL GORE &ASSOCIATES）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • COOK
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • JOTEC（CRYOLIFE, INC.）
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
    • LOMBARD MEDICAL
      • 公司簡介
      • 財務績效
      • 產品基準
      • 戰略舉措
Product Code: GVR-3-68038-043-9

Aortic Aneurysm Market Growth & Trends:

The global aortic aneurysm market size is expected to reach USD 6.5 billion by 2030 and the global aortic aneurysm treatment market size is expected to reach USD 10.4 billion by 2030, expanding at a CAGR of 10.51% from 2022 to 2030, according to a new report by Grand View Research, Inc.

The growing geriatric population in developed countries, rapid adoption of sedentary lifestyles, and a rise in the number of tobacco smokers are expected to be the key factors driving the global market. According to a study published by the American Heart Association Inc., it was found that smoking was considered to be responsible for 75% of the excess prevalence of AAAs ≥4 cm. Furthermore, technological advancements in endovascular surgical procedures will augment the industry's growth.

Cases of abdominal aortic aneurysms, especially in men aged 65 years and above, surpassed the number of thoracic aortic aneurysms by threefold. This has increased the demand for advanced stent-graft systems for AAA. Due to the lack of multiple treatment options and being a complex procedure, TAA procedures are fewer. This offers a lucrative opportunity to the manufacturers for developing advanced products for Thoracic Endovascular Aneurysm Repair (TEVAR).

The COVID-19 pandemic negatively impacted the AA market. Many government associations such as the American College of Surgeons and the French Vascular Surgical Society recommended the postponement of uncomplicated AA procedures. Many hospitals limited surgical activity related to aortic diseases, with EAVR being preferred over open surgery. As a result, the sales of AA devices reported a sharp decline. For instance, the endovascular segment of Microport Scientific Corporation witnessed a decline of 42.1% in revenue in 2021.

Aortic Aneurysm Market Report Highlights:

  • Based on type, the AAA segment dominated the market in 2021. The rising number of AAA cases, the presence of government programs for early screening, and increasing demand for minimally invasive procedures are driving the segment
  • In terms of product, stent-grafts held the largest revenue share in 2021 as they have more than 50% share in the overall surgical treatment cost of a patient
  • Based on end-use, the hospital's segment is expected to flourish owing to a rise in technological advancement and high procedure volume
  • By treatment, Endovascular Aortic Aneurysm Repair (EVAR), which includes minimally invasive surgeries, is expected to be the fastest-growing segment over the forecast period as it is more efficient than open repair due to fewer postsurgical adverse effects
  • North America held the largest revenue share in 2021, followed by Europe, on account of well-established healthcare infrastructure, access to advanced screening and diagnostic tools for AAA, and favorable reimbursement scenario in the region
  • In August 2021, Terumo Corporation received approval by the U.S. FDA for its RelayPro Thoracic Stent-Graft System to be sold in the U.S. to treat patients with thoracic aortic aneurysm and penetrating atherosclerotic ulcers

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
    • 2.1.2 Purchased Database
    • 2.1.3 GVR's Internal Database
    • 2.1.4 Secondary Sources
    • 2.1.5 Primary Research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data Analysis Models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Volume Price Analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Abbreviations

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Type
    • 3.2.2 Treatment
    • 3.2.3 Product
    • 3.2.4 End-use
  • 3.3 Regional Outlook
  • 3.4 Competitive Insights

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Related/Ancillary Market Outlook
  • 4.2 Aortic Aneurysm Market Dynamics
    • 4.2.1 Market Driver Analysis
    • 4.2.2 Market Restraint Analysis
  • 4.3 Aortic Aneurysm Market: Business Environment Analysis Tools
    • 4.3.1 Porter's five forces analysis
      • 4.3.1.1 Threat of new entrants
      • 4.3.1.2 Bargaining power of buyers
      • 4.3.1.3 Competitive rivalry
      • 4.3.1.4 Threat of substitutes
      • 4.3.1.5 Bargaining power of suppliers
    • 4.3.2 PESTLE Analysis
      • 4.3.2.1 Political & legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Qualitative Analysis: Impact of COVID-19 on Aortic Aneurysm Market

Chapter 5 Aortic Aneurysm Market: Type Analysis

  • 5.1 Aortic Aneurysm Type Market Share Analysis, 2021 & 2030
  • 5.2 Aortic Aneurysm Type Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the Type Segment
    • 5.3.1 Thoracic Aortic Aneurysm (TAA)
      • 5.3.1.1 Thoracic aortic aneurysm (TAA) market, 2016 - 2030 (USD Million)
    • 5.3.2 Abdominal Aortic Aneurysm (AAA)
      • 5.3.2.1 Abdominal aortic aneurysm (AAA)market, 2016 - 2030 (USD Million)

Chapter 6 Aortic Aneurysm Market: Treatment Analysis

  • 6.1 Aortic Aneurysm TreatmentMarket Share Analysis, 2021 & 2030
  • 6.2 Aortic Aneurysm TreatmentMarket: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the TreatmentSegment
    • 6.3.1 Open Surgical Repair (OSR)
      • 6.3.1.1 Open surgical repair market, 2016 - 2030 (USD Million)
    • 6.3.2 Endovascular Aneurysm Repair (EVAR)
      • 6.3.2.1 Endovascular aneurysm repair (EVAR) market, 2016 - 2030 (USD Million)

Chapter 7 Aortic Aneurysm Market: Product Analysis

  • 7.1 Aortic Aneurysm ProductMarket Share Analysis, 2021 & 2030
  • 7.2 Aortic Aneurysm Product Market: Segment Dashboard
  • 7.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the ProductSegment
    • 7.3.1 Stent Grafts
      • 7.3.1.1 Stent grafts market, 2016 - 2030 (USD Million)
    • 7.3.2 Catheter
      • 7.3.2.1 Catheter market, 2016 - 2030 (USD Million)

Chapter 8 Aortic Aneurysm Market: End-Use Analysis

  • 8.1 Aortic Aneurysm End-Use Market Share Analysis, 2021 & 2030
  • 8.2 Aortic Aneurysm End-Use Market: Segment Dashboard
  • 8.3 Market Size & Forecasts and Trend Analyses, 2016 - 2030 for the End-Use Segment
    • 8.3.1 Hospitals
      • 8.3.1.1Hospitals market, 2016 - 2030 (USD Million)
    • 8.3.2 Ambulatory Surgery Centers
      • 8.3.2.1 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
    • 8.3.3 Clinics
      • 8.3.3.1 Clinics market, 2016 - 2030 (USD Million)

Chapter 9 Aortic Aneurysm Market: Regional Analysis

  • 9.1 Aortic Aneurysm Regional Market Share Analysis, 2021 & 2030
  • 9.2 Regional Market Snapshot
  • 9.3 Market Size, & Forecasts and Trend Analysis, 2016 to 2030
    • 9.3.1 North America
      • 9.3.1.1 North America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.2 U.S.
      • 9.3.1.2.1 U.S. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.1.3 Canada
      • 9.3.1.3.1 Canada Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.2 Europe
      • 9.3.2.1 Europe Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.2 U.K.
      • 9.3.2.2.1 U.K. Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.3 Germany
      • 9.3.2.3.1 Germany Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.4 France
      • 9.3.2.4.1 France Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.5 Italy
      • 9.3.2.5.1 Italy Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.2.6 Spain
      • 9.3.2.6.1 Spain Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.3 Asia Pacific
      • 9.3.3.1 Asia Pacific Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.2 Japan
      • 9.3.3.2.1 Japan Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.3 China
      • 9.3.3.3.1 China Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.4 India
      • 9.3.3.4.1 India Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.5 Australia
      • 9.3.3.5.1 Australia Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.3.6 South Korea
      • 9.3.3.6.1South Korea Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.4 Latin America
      • 9.3.4.1 Latin America Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.2 Mexico
      • 9.3.4.2.1 Mexico Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.4.3 Brazil
      • 9.3.4.3.1 Brazil Aortic Aneurysm Market, 2016 - 2030 (USD Million)
    • 9.3.5 Middle East & Africa
      • 9.3.5.1 MiddleEast & Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.2 South Africa
      • 9.3.5.2.1 South Africa Aortic Aneurysm Market, 2016 - 2030 (USD Million)
      • 9.3.5.3 Saudi Arabia
      • 9.3.5.3.1 Saudi Arabia Aortic Aneurysm Market, 2016 - 2030 (USD Million)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.3 Company Market Position Analysis
  • 10.4 company profiles
    • 10.4.1 MEDTRONIC
      • 10.4.1.1 Company overview
      • 10.4.1.2 Financial performance
      • 10.4.1.3 Product benchmarking
      • 10.4.1.4 Strategic initiatives
    • 10.4.2 TERUMO CORPORATION
      • 10.4.2.1 Company overview
      • 10.4.2.2 Financial performance
      • 10.4.2.3 Product benchmarking
      • 10.4.2.4 Strategic initiatives
    • 10.4.3 ENDOLOGIX LLC
      • 10.4.3.1 Company overview
      • 10.4.3.2 Financial performance
      • 10.4.3.3 Product benchmarking
      • 10.4.3.4 Strategic initiatives
    • 10.4.4 MICROPORT SCIENTIFIC CORPORATION
      • 10.4.4.1 Company overview
      • 10.4.4.2 Financial performance
      • 10.4.4.3 Product benchmarking
      • 10.4.4.4 Strategic initiatives
    • 10.4.5 GORE MEDICAL (W. L. GORE & ASSOCIATES)
      • 10.4.5.1 Company overview
      • 10.4.5.2 Financial performance
      • 10.4.5.3 Product benchmarking
      • 10.4.5.4 Strategic initiatives
    • 10.4.6 COOK
      • 10.4.6.1 Company overview
      • 10.4.6.2 Financial performance
      • 10.4.6.3 Product benchmarking
      • 10.4.6.4 Strategic initiatives
    • 10.4.7 JOTEC (CRYOLIFE, INC.)
      • 10.4.7.1 Company overview
      • 10.4.7.2 Financial performance
      • 10.4.7.3 Product benchmarking
      • 10.4.7.4 Strategic initiatives
    • 10.4.8 LOMBARD MEDICAL
      • 10.4.8.1 Company overview
      • 10.4.8.2 Financial performance
      • 10.4.8.3 Product benchmarking
      • 10.4.8.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 North America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 4 North America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 5 North America Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 6 North America Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 7 North America Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 8 U.S. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 9 U.S. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 10 U.S. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 11 U.S. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 12 Canada Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 13 Canada Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 14 Canada Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 15 Canada Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 16 Europe Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 17 Europe Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 18 Europe Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 19 Europe Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 20 Europe Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 U.K. Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 22 U.K. Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 23 U.K. Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 24 U.K. Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25Germany Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 26 Germany Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 27 Germany North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 28 Germany Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 France Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 30 France Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 31 France North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 32 France Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Italy Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 34 Italy Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 35 Italy North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 36 Italy Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Spain Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 38 Spain Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 39 Spain North Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 40 Spain Aortic Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Asia Pacific Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 42 Asia Pacific Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 43 Asia Pacific Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 44 Asia Pacific Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 45 Asia Pacific Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 46 Japan Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 47 Japan Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 48 Japan Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 49 Japan Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 50 China Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 51 China Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 52 China Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 53 China Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 54 India Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 55 India Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 56 India Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 57 India Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 58 Australia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 59 Australia Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 60 Australia Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 61 Australia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 62 South Korea Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 63 South Korea Aortic Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 64 South Korea Aortic Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 65 South Korea Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 66 Latin America Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 67 Latin America Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 68 Latin America Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 69 Latin America Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 70 Latin America Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 71 Brazil Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 72 Brazil Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 73 Brazil Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 74 Brazil Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 75 Mexico Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 76 Mexico Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 77 Mexico Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 78 Mexico Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 79 Middle East & Africa Aortic Aneurysm Market, by Country, 2016 - 2030 (USD Million)
  • TABLE 80 Middle East & Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 81 Middle East & Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 82 Middle East & Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 83 Middle East & Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 84 South Africa Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 85 South Africa Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 86 South Africa Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 87 South Africa Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 88 Saudi Arabia Aortic Aneurysm Market, by Type, 2016 - 2030 (USD Million)
  • TABLE 89 Saudi Arabia Aneurysm Market, by Treatment, 2016 - 2030 (USD Million)
  • TABLE 90 Saudi Arabia Aneurysm Market, by Product, 2016 - 2030 (USD Million)
  • TABLE 91 Saudi Arabia Aneurysm Market, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook
  • FIG. 9 Aortic aneurysm market segmentation
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 Market dynamics
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Market restraint relevance analysis (Current & future impact)
  • FIG. 14 Aortic aneurysm type market share analysis, 2021 & 2030
  • FIG. 15 Aortic aneurysm type market: Segment dashboard
  • FIG. 16 Thoracic aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 17 Abdominal aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 18 Aortic aneurysm treatment type market share analysis, 2021 & 2030
  • FIG. 19 Aortic aneurysm treatment type market: Segment dashboard
  • FIG. 20 Open surgical repair market, 2016 - 2030 (USD Million)
  • FIG. 21 Endovascular aneurysm repair(EVAR), 2016 - 2030 (USD Million)
  • FIG. 22 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 23 Aortic Aneurysm Product Market: Segment dashboard
  • FIG. 24 Stent grafts market, 2016 - 2030 (USD Million)
  • FIG. 25 Catheters market, 2016 - 2030 (USD Million)
  • FIG. 26 Aortic aneurysm product market share analysis, 2021 & 2030
  • FIG. 27 Aortic aneurysm product market: Segment dashboard
  • FIG. 28 Hospitals market, 2016 - 2030 (USD Million)
  • FIG. 29 Ambulatory surgery centers market, 2016 - 2030 (USD Million)
  • FIG. 30 Clinics market, 2016 - 2030 (USD Million)
  • FIG. 31 Aortic aneurysm regional market share analysis, 2021 & 2030
  • FIG. 32 Aortic aneurysm regional market: Segment dashboard
  • FIG. 33 Regional marketplace: Key takeaways
  • FIG. 34 North America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 35 U.S. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 36 Canada aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 37 Europe aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 38 U.K.. aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 39 Germany aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 40 France aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 41 Italy aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 42 Spain aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 43 Asia Pacific aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 44 Japan aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 45 China aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 46 India aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 47 Australia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 48 South Korea aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 49 Latin America aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 50 Brazil aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 51 Mexico aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 52 MEA aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 53South Africa aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 54 Saudi Arabia aortic aneurysm market, 2016 - 2030 (USD Million)
  • FIG. 55 Recent developments & impact analysis, by key market participants
  • FIG. 56 Strategic framework/ competition categorization
  • FIG. 57 Company market position analysis